Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Marksans Pharma Limited ( (IN:MARKSANS) ) has issued an update.
Marksans Pharma Limited has strengthened its international footprint by incorporating two new wholly owned subsidiaries: Marksans Pharma (Europe) Limited in Ireland and Marksans (Canada) Inc. in Canada. Both entities, newly formed and without prior turnover, have been set up to conduct pharmaceutical business in their respective regions, signalling a strategic push to deepen Marksans’ presence in key regulated markets and potentially enhance its global distribution, regulatory alignment and market access in Europe and North America.
More about Marksans Pharma Limited
Marksans Pharma Limited is an India-headquartered pharmaceutical company engaged in the development, manufacturing and marketing of pharmaceutical products for global markets. The company focuses on regulated markets such as Europe and North America, supplying a range of generic and specialty medicines across various therapeutic segments.
Average Trading Volume: 55,457
Technical Sentiment Signal: Hold
Current Market Cap: 73.91B INR
For a thorough assessment of MARKSANS stock, go to TipRanks’ Stock Analysis page.